drugset / Trial / NCT07521345
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Food Effect of HSK55879 Tablets in Healthy Subjects.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a single-center, random, double blind, placebo control clinical study to evaluate the safety, tolerability pharmacokinetics and food effect of HSK55879 in healthy subjects
Timeline
- Start
- 2026-03-20
- Primary completion
- 2026-06-01
- Completion
- 2026-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HSK55879 | Unknown | — | Oral |
Indications
No indication recorded.